CLINICAL_TRIALS
trial_result
· 2014-08-12
Clinical Trial Update: A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer [Phase 2]
Summary
Phase II trial evaluating imatinib (STI571) for metastatic gastric cancer has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Gastric Cancer, Stage IV Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-12